These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 12825092)
1. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Alsene K; Deckert J; Sand P; de Wit H Neuropsychopharmacology; 2003 Sep; 28(9):1694-702. PubMed ID: 12825092 [TBL] [Abstract][Full Text] [Related]
2. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Rogers PJ; Hohoff C; Heatherley SV; Mullings EL; Maxfield PJ; Evershed RP; Deckert J; Nutt DJ Neuropsychopharmacology; 2010 Aug; 35(9):1973-83. PubMed ID: 20520601 [TBL] [Abstract][Full Text] [Related]
3. Effects of ADORA2A gene variation and caffeine on prepulse inhibition: a multi-level risk model of anxiety. Gajewska A; Blumenthal TD; Winter B; Herrmann MJ; Conzelmann A; Mühlberger A; Warrings B; Jacob C; Arolt V; Reif A; Zwanzger P; Pauli P; Deckert J; Domschke K Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():115-21. PubMed ID: 22940476 [TBL] [Abstract][Full Text] [Related]
4. Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Hohoff C; McDonald JM; Baune BT; Cook EH; Deckert J; de Wit H Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):42-4. PubMed ID: 16118787 [TBL] [Abstract][Full Text] [Related]
5. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Childs E; Hohoff C; Deckert J; Xu K; Badner J; de Wit H Neuropsychopharmacology; 2008 Nov; 33(12):2791-800. PubMed ID: 18305461 [TBL] [Abstract][Full Text] [Related]
6. Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Lam P; Hong CJ; Tsai SJ Neurosci Lett; 2005 Apr; 378(2):98-101. PubMed ID: 15774265 [TBL] [Abstract][Full Text] [Related]
7. A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Rétey JV; Adam M; Khatami R; Luhmann UF; Jung HH; Berger W; Landolt HP Clin Pharmacol Ther; 2007 May; 81(5):692-8. PubMed ID: 17329997 [TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial. Renda G; Committeri G; Zimarino M; Di Nicola M; Tatasciore A; Ruggieri B; Ambrosini E; Viola V; Antonucci I; Stuppia L; De Caterina R Eur Neuropsychopharmacol; 2015 Jun; 25(6):798-807. PubMed ID: 25819143 [TBL] [Abstract][Full Text] [Related]
9. More on ADORA. Yang A; Childs E; Palmer AA; de Wit H Psychopharmacology (Berl); 2010 Dec; 212(4):699-700. PubMed ID: 20802997 [No Abstract] [Full Text] [Related]
10. The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo. Riksen NP; Franke B; van den Broek P; Smits P; Rongen GA Pharmacogenet Genomics; 2007 Jul; 17(7):551-4. PubMed ID: 17558310 [TBL] [Abstract][Full Text] [Related]
11. ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex. Domschke K; Gajewska A; Winter B; Herrmann MJ; Warrings B; Mühlberger A; Wosnitza K; Glotzbach E; Conzelmann A; Dlugos A; Fobker M; Jacob C; Arolt V; Reif A; Pauli P; Zwanzger P; Deckert J Neuropsychopharmacology; 2012 Feb; 37(3):759-69. PubMed ID: 22012471 [TBL] [Abstract][Full Text] [Related]
12. Involvement of adenosinergic receptors in anxiety related behaviours. Kulkarni SK; Singh K; Bishnoi M Indian J Exp Biol; 2007 May; 45(5):439-43. PubMed ID: 17569285 [TBL] [Abstract][Full Text] [Related]
13. Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease. Tan EK; Lu ZY; Fook-Chong SM; Tan E; Shen H; Chua E; Yih Y; Teo YY; Zhao Y Am J Med Genet B Neuropsychiatr Genet; 2006 Sep; 141B(6):634-6. PubMed ID: 16823803 [TBL] [Abstract][Full Text] [Related]
14. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Huang ZL; Qu WM; Eguchi N; Chen JF; Schwarzschild MA; Fredholm BB; Urade Y; Hayaishi O Nat Neurosci; 2005 Jul; 8(7):858-9. PubMed ID: 15965471 [TBL] [Abstract][Full Text] [Related]
15. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Nardi AE; Lopes FL; Freire RC; Veras AB; Nascimento I; Valença AM; de-Melo-Neto VL; Soares-Filho GL; King AL; Araújo DM; Mezzasalma MA; Rassi A; Zin WA Psychiatry Res; 2009 Sep; 169(2):149-53. PubMed ID: 19698996 [TBL] [Abstract][Full Text] [Related]
16. Impact of Genetic Variability on Physiological Responses to Caffeine in Humans: A Systematic Review. Fulton JL; Dinas PC; Carrillo AE; Edsall JR; Ryan EJ; Ryan EJ Nutrients; 2018 Sep; 10(10):. PubMed ID: 30257492 [TBL] [Abstract][Full Text] [Related]
17. DARPP chocolate: a caffeinated morsel of striatal signaling. Bastia E; Schwarzschild MA Sci STKE; 2003 Jan; 2003(165):PE2. PubMed ID: 12527819 [TBL] [Abstract][Full Text] [Related]